Ignoring the fact there are no IP barriers to entry should Radiogel be approved. All the original patents have expired. Only way to keep out generics is to price Radiogel low enough it won't be worth the effort to compete. So any buyout price will be reduced accordingly.
News 
Market Data 
Discover 
